卵巢肿块良恶性鉴别:国际卵巢肿瘤分析超声规则的价值
卵巢癌是妇科癌症中死亡率最高的癌症,早期发现生存率可超90%,超声是目前鉴别良恶性的最佳方法。国际卵巢肿瘤分析(IOTA)的超声简单规则与ADNEX模型敏感度分别为92%和96.5%,特异度分别为96%和71.3%。作者建议在美国验证并广泛应用这些模型。
要点
- 超声简单规则将肿瘤分类为良性、恶性或不确定,ADNEX模型评估良恶性风险及恶性分期风险。
- 简单规则与ADNEX模型(恶性截断值10%)敏感度分别为92%和96.5%,特异度分别为96%和71.3%。
- 作者建议这些模型应在美国验证并广泛引入临床实践。
核心结论
- 简单规则和ADNEX模型是附件肿瘤术前分类的最佳预测工具,旨在帮助专科医生对持续性卵巢肿块患者做出管理决策。
- 作者建议这些模型应在医学实践中验证并广泛引入美国临床实践。
研究设计与样本
- 本文为综述,汇总了国际卵巢肿瘤分析(IOTA)发布的超声简单规则和ADNEX模型的相关数据。
主要发现
- 卵巢癌是女性癌症死亡的第五大原因,在所有妇科癌症中死亡率最高。
- 总体生存率低于50%,但若早期发现可达90%。
- 超声目前是鉴别良恶性的最佳方法。
- 简单规则将肿瘤分类为良性、恶性或不确定;ADNEX模型确定肿瘤良恶性风险,若为恶性则评估各分期风险。
- 简单规则与ADNEX模型(采用10%截断值预测恶性)的敏感度分别为92%和96.5%,特异度分别为96%和71.3%。
关键数值与推荐
- 简单规则敏感度92%,特异度96%。
- ADNEX模型采用10%截断值预测恶性时敏感度96.5%,特异度71.3%。
临床怎么用
- 作者建议这些模型应在医学实践中验证并广泛引入美国临床实践。
局限性
- 这些模型已在多篇报告中验证,但尚未在美国验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ovarian cancer, the fifth most common cause of cancer death among women, has the highest mortality rate of all gynecologic cancers. General survival rate is <50% but can reach 90% if disease is detected early. Ultrasound is presently the best modality to differentiate between benign and malignant status. The patient with a malignant mass should be referred to an oncology surgeon since results have been shown to be superior to treatment by a specialist. Several ultrasound-based scoring systems exist for assessing the risk of an ovarian tumor to be malignant. The International Ovarian Tumor Analysis group published 2 such systems: the ultrasound Simple Rules and the Assessment of Different NEoplasias in the adneXa model. The Simple Rules classifies a tumor as benign, malignant, or indeterminate and the Assessment of Different NEoplasias in the adneXa model determines the risk for a tumor to be benign or malignant and, if malignant, the risk of various stages. Sensitivity of the Simple Rules and Assessment of Different NEoplasias in the adneXa model (using a cut-off of 10% to predict malignancy) are 92% and 96.5%, respectively, and specificities are 96% and 71.3%, respectively. These models are the best predictive tests for the preoperative classification of adnexal tumors. Their intent is to help the specialist make management decisions when faced with a patient with a persistent ovarian mass. The models are simple, are easy to use, and have been validated in multiple reports but not in the United States. We suggest they should be validated and widely introduced into medical practice in the United States.
引用
- Abramowicz JS, Timmerman D. Ovarian mass-differentiating benign from malignant: the value of the International Ovarian Tumor Analysis ultrasound rules. Am J Obstet Gynecol. 2017. PMID: 28735703. doi:10.1016/j.ajog.2017.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。